Opsens was informed by the distributor that optowire was advanced into a significantly calcified lesion in the lad, it was noticed that the wire was broken where proximal radiopaque section stops.Wire tip was safely removed, and patient is doing well.Opsens was informed by the distributor that optowire was advanced into a significantly calcified lesion in the lad, it was noticed that the wire was broken where proximal radiopaque section stops.Wire tip was safely removed, and patient is doing well.
|
The optowire iii could not be analysed since it was discarded by the hospital after the procedure.Review of device history records confirmed that the optowire iii lot number ow-2617e had been released as per specifications, dr610 was recorded, but not related to the complaint.Based on the available event description and following discussion with the distributor representative, the wire was fractured at the end of the distal radiopaque section.The cause of the fracture is likely related to the usage of the device beyond the recommendations provided in the instructions for use (ifu): -if resistance occurs and the cause of resistance cannot be determined, do not move or torque the optowire.Stop the procedure, determine the cause of resistance under fluoroscopy and take appropriate action.-observe optowire movement in the vessels.Before an optowire is moved or torqued, the tip movement should be examined under fluoroscopy.Do not torque an optowire without observing corresponding movement of the tip; otherwise, vessel trauma may occur.-never advance an optowire against resistance without first determining the reason for the resistance under fluoroscopy.Excessive force against resistance may result in damage to the wire and/or to the vessel.
|